Acer Therapeutics Inc (ACER) is around the middle of the Biotechnology industry according to InvestorsObserver. ACER received an overall rating of 52, which means that it scores higher than 52 percent of all stocks. Acer Therapeutics Inc also achieved a score of 58 in the Biotechnology industry, putting it above 58 percent of Biotechnology stocks. Biotechnology is ranked 27 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Acer Therapeutics Inc Stock Today?
Acer Therapeutics Inc (ACER) stock is down -7.03% while the S&P 500 has gained 1.25% as of 2:05 PM on Wednesday, Sep 30. ACER is down -$0.22 from the previous closing price of $3.13 on volume of 508,326 shares. Over the past year the S&P 500 is higher by 14.86% while ACER is down -0.34%. ACER lost -$2.08 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Acer Therapeutics Inc (ACER) Stock.
